Literature DB >> 23667870

Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin-induced diabetes.

N G Lotosh1, E K Savel'eva, A A Selishcheva, S V Savel'ev.   

Abstract

The appearance of autoantibodies to neuronal proteins (S100, GFAP, MBP, and NGF) in rat serum was analyzed by ELISA on days 5, 10, 17, 25, and 32 after streptozotocin injection. Simultaneously, blood glucose and insulin autoantibodies were assayed. Serum glucose level increased on the next day after streptozotocin injection and the level of autoantibodies to insulin significantly increased on day 5 indicating the development of diabetes. The levels of antibodies to specific neuronal proteins (S100, GFAP, MBP, and NGF) also increased at this term. It is concluded that diabetes with streptozotocin is associated with damage to the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23667870     DOI: 10.1007/s10517-013-2077-5

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients.

Authors:  Georgene W Hergenroeder; Anthony N Moore; Karl M Schmitt; John B Redell; Pramod K Dash
Journal:  Neuroreport       Date:  2016-01-20       Impact factor: 1.837

2.  Microwave-accelerated bioassay technique for rapid and quantitative detection of biological and environmental samples.

Authors:  Muzaffer Mohammed; Maleeha F Syed; Kadir Aslan
Journal:  Biosens Bioelectron       Date:  2015-08-31       Impact factor: 10.618

Review 3.  Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.

Authors:  Sherman S Leung; Josephine M Forbes; Danielle J Borg
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.